[1]
“Assessment of interleukin -10 and interferon-gamma with oral squamous cell carcinoma patients compared with healthy subjects as a prediction for early detection and monitor treatment response”, MDJ, vol. 16, no. 1, pp. 68–77, Jan. 2024, doi: 10.32828/mdj.v16i1.1026.